| Net cash flow from operating activities |
|
|
|
|
|
|
| Profit/(loss) for the period |
|
|
|
–2 181 |
|
7 973 |
| Income taxes (income)/expenses |
|
28
|
|
1 111 |
|
3 638 |
| Interest expenses |
|
9
|
|
2 747 |
|
2 509 |
| Dividend income from non-current assets |
|
9
|
|
–119 |
|
–42 |
| Profit/(loss) for the period before interest and tax |
|
|
|
1 558 |
|
14 078 |
| Depreciation, amortization and impairment |
|
8
|
|
3 882 |
|
4 494 |
| Value adjustment on non-current financial assets |
|
|
|
– |
|
–576 |
| (Profit)/loss on sale of non-current assets |
|
3
|
|
62 |
|
–495 |
| Gain recognized on contribution of net assets into associate |
|
7
|
|
–1 368 |
|
– |
| Share of (profit)/loss of associates |
|
13
|
|
354 |
|
–438 |
| Disposal of financial liabilities as a result of forgiveness |
|
|
|
– |
|
–66 |
| Changes in provisions |
|
26
|
|
186 |
|
–560 |
| Increase obsolence reserve on inventories |
|
15
|
|
900 |
|
1 235 |
| Change in fair value of biological assets |
|
11
|
|
–927 |
|
–13 455 |
| Other non-cash items |
|
|
|
–87 |
|
–73 |
| Operating cash flow before working capital changes |
|
|
|
4 560 |
|
4 143 |
| Decrease/(increase) in trade and other receivables |
|
17
|
|
–5 973 |
|
943 |
| Decrease/(increase) in inventories |
|
15
|
|
–382 |
|
–3 210 |
| Decrease/(increase) in prepayments and assets held for sale |
|
|
|
824 |
|
812 |
| Increase/(decrease) in trade payables and other liabilities |
|
18
|
|
7 112 |
|
1 288 |
| Income tax (paid)/received |
|
28
|
|
–273 |
|
–170 |
| Net cash flow operating activities |
|
|
|
5 868 |
|
3 806 |
| |
| Cash flow from investing activities |
| Purchase of intangible assets |
|
12
|
|
–125 |
|
–53 |
| Proceeds from sale of property, plant and equipment |
|
7 / 10
|
|
33 |
|
950 |
| Purchase of property, plant and equipment |
|
10
|
|
–3 994 |
|
–5 691 |
| Issuance of financial assets to associates |
|
|
|
–291 |
|
– |
| Proceeds from disposal of other non-current assets |
|
|
|
342 |
|
27 |
| Purchase of other non-current assets |
|
|
|
–260 |
|
–161 |
| Increase/(decrease) in recoverable taxes |
|
|
|
– |
|
–23 |
| Dividends from associates |
|
13
|
|
138 |
|
259 |
| Dividends from non-current financial assets |
|
9
|
|
119 |
|
42 |
| Net cash flow investing activities |
|
|
|
–4 038 |
|
–4 650 |
| |
| Cash flow from financing activities |
| Proceeds from borrowings |
|
19
|
|
2 141 |
|
7 796 |
| Repayment of borrowings |
|
19
|
|
–1 270 |
|
–5 668 |
| Interests paid |
|
19
|
|
–1 492 |
|
–1 426 |
| Interests paid on lease liabilities |
|
19 / 21
|
|
–127 |
|
–65 |
| Repayment of lease liabilities |
|
19 / 21
|
|
–815 |
|
–86 |
| Net cash flow financing activities |
|
|
|
–1 563 |
|
552 |
| |
|
|
|
|
|
|
| Net increase/(decrease) in cash and cash equivalents |
|
|
|
267 |
|
–292 |
| |
|
|
|
|
|
|
| Cash and cash equivalents, at the beginning of the year |
|
|
|
2 578 |
|
2 798 |
| Increase/(decrease) in cash and cash equivalents |
|
|
|
267 |
|
–292 |
| Translation effect on cash |
|
|
|
–67 |
|
72 |
| Total Cash and cash equivalents, at the end of the year |
|
|
|
2 778 |
|
2 578 |